Table 4.
Overview of stage, overall survival and tumour-free survival of 550 tumour-free patients after initial therapy stratified for neoadjuvant systemic therapy
| Perioperative vs. no perioperative therapy (n = 550) | |||
|---|---|---|---|
| Perioperative therapy | No perioperative therapy | P | |
| n = 64 | n = 486 | ||
| pUICC7 I | 24 | 224 | 0.47 |
| (37.5%) | (46.1%) | ||
| pUICC7 II | 28 | 197 | |
| (43.8%) | (40.5%) | ||
| pUICC7 III | 11 | 56 | |
| (17.2%) | (11.5%) | ||
| pUICC7 X | 1 | 9 | |
| (1.6%) | (1.9%) | ||
| Median overall survival (months) | Not reached | Not reached | 0.41 |
| 75%-survival (months) (Standard error) | 28.9% (±6.1) | 36%.9 (±4.4) | |
| Time to recurrence (25% of patients) (Standard error) | 17.0 (±5.5) months | 25.0 (±2.5) months | 0.82 |